Its genetic inactivation constitutes the PGBD5 deficiency disorder, characterized by developmental delay, intellectual disability, language and motor impairments, seizures, and reductions in corpus callosum and cerebellar size. The gene discussed is PGBD5; the disease is Intellectual disability.